New higher viscosity TetraVisc™ FORTE provides a longer anesthetization time than traditional ophthalmic anesthetic solutions and significantly improves pain levels in postoperative patients. Additionally, TetraVisc™ FORTE also offers a number of advantages over anesthetic jelly (commonly used off-label for a number of years in cataract surgery) including: rapid and immediate dispersion across the cornea eliminating the need for multiple drops or supplemental intracameral anesthesia and increased efficiency in the operating room or the clinic. Call 800-233-5469 for a trial evaluation.